Rebiotix, based in Roseville, Minnesota, and Ferring Pharmaceuticals, with headquarters in Saint-Prex, Switzerland, announced positive preliminary results from the companies’ ongoing pivotal Phase III trial of RBX2660.

Arcadia Consumer Healthcare Inc., (formerly Kramer Laboratories Inc.) a recognized leader in the consumer healthcare industry, announced that the company completed the acquisition of the U.S. rights to the Kaopectate brand from Sanofi.

The U.S. Food and Drug Administration approved Merck’s Dificid (fidaxomicin) for a new oral suspension as well as for the treatment of Clostridioides difficile-associated diarrhea (CDAD) in children ages 6 months and older.

Bausch Health Companies Inc., together with wholly owned subsidiary Salix Pharmaceuticals Inc.’s licensor Alfasigma SpA, announced the filing of a lawsuit against Sandoz Inc. alleging patent infringement of 14 patents by the Novartis division’s submission of an Abbreviated New Drug Application for Xifaxan

(rifaximin) 550 mg tablets.

Sangamo Therapeutics Inc.’s shares sank 27 percent after the company’s gene-editing drug failed to show promise in an early-stage trial testing for patients with ultra-rare disorders.

The U.S. FDA approved Aries Pharmaceuticals Inc.’s Aemcolo (rifamycin) for the treatment of adult patients with Travelers’ Diarrhea caused by non-invasive strains of Escherichia coli.

A deadly viral outbreak claimed the life of a seventh child at a New Jersey rehabilitation center, where 11 other medically fragile young patients remain hospitalized with adenovirus infections, state health officials said.

Johnson & Johnson reported a strong first-quarter 2018 with $20 billion in sales that was fueled by significant growth in the company’s pharmaceuticals business.

Pyeongchang Winter Olympics organizers (POCOG) said on Monday a total of 177 norovirus cases had been confirmed so far at the Games, but that the athletic delegations remained unaffected.

The number of people struck down by a virus causing vomiting and diarrhea at the Pyeongchang Winter Olympics has more than doubled to 86, though athletes remain unaffected, the Korean Centers for Disease Control and Prevention (KCDC) said.